维普期刊资源整合服务平台（V6.5）

65篇 您的检索式：作者名="Mischak"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	The molecular make-up of a tumour: proteomics in cancer research显示文摘	Kolch W Mischak H Pitt A R	2005	Clin Sci (Lond)2005，108，5：	1
2	Proteomics in uremia and renal disease显示文摘	Mischak H Massy ZA Jankowski J	2009	Semin Dial2009，22，4：	1
3	Exploring the uremic toxins using proteomic technologies显示文摘	Schiffer E Mischak H Vanholder RC	2008	Contrib Nephrol2008，160，：	1
4	Overexpression of protein kinase C-δ and -ε in NIH 3T3 cells induces opposite effects on growth,morphology,anchorage dependence,and tumorigenicity显示文摘	Mischak H Goodnight J Kolch W	1993	J Biol Chem1993，201，9：	1
5	Proteomic analysis for the assessment of diabetic renal damage in humans显示文摘	Mischak H Kaiser T Walden M etal	2004	Clin Sci (Lond)2004，107，5：	1
6	Proteomic analysis for the assessment of diabetic renal damage in humans显示文摘	Mischak H Kaiser T Walden M	2004	Clin Sci2004，107，：	1
7	How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE ‐ MS显示文摘	Harald Mischak	2012	Prot. Clin. Appl. . 2012 (9-10)2012，，9：	1
8	Haemodialysis, atherosclerosis and inflammation -identifying molecular mechanisms of chronic vascular disease in ESRD patients显示文摘	Walter R Mischak H Hailer H	2002	Nephrol Dial Transplant2002，17，3：	1
9	Clinical application of urinary proteomics/peptidomics显示文摘	Albalat A Mischak H Mullen W		0，，05：	1
10	Urine proteomics in clinical applications:technologies,principal considerations and clinical implementation显示文摘	Albalat A Mischak H Mullen W		0，，01：	1
11	Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes显示文摘	Pena M J de Zeeuw D Mischak H	2015	Nephrol Dial Transplant2015，30，4：	1
12	Chal- lenges of using mass spectrometry as a bladder cancer biomarker discovery platform显示文摘	SCHIFFER E MISCHAK H THEODORESCU D	2008	World J Urol2008，26，1：	1
13	Proteomics in uremia and renal disease显示文摘	Mischak H Massy ZA Jankowski J	2009	Semin Dial2009，22，4：	1
14	Proteomics in uremia and renal disease显示文摘	Mischak H Massy ZA Jankowski J	2009	Semin Dial2009，22，4：	1
15	Proteomic analysis for the assessment of diabetic renal damage in humans显示文摘	Mischak H Kaiser T Walden M	2004	Clin Sci(Lond)2004，107，5：	1
16	Cell type - specific activation of mitogen- activated protein kinases by CpG-DNA controls interleukin- 12 release from antigen- presenting cells显示文摘	Hacker H Mischak H Hacker G	1999	EMBO J1999，18，24：	1
17	Mechanism of inhibition of Raf-1 by protein kinase A显示文摘	Adler HS Mischak H	1994	Mol Cell Biol1994，14，：	1
18	Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease:discovery and validation of biomarkers,and clinical application显示文摘	Mischak H Delles C Klein J Schanstra J P		0，，06：	1
19	A novel systemically active caspase inhibitor attenuates the toxicities of MPTP,malonate,and 3NP in vivo显示文摘	Yang L Sugama S Mischak RP	2004	Neurobiol Dis2004，17，2：	1
20	Negative regulation of Raf-1 by phosphorylation of serine 621显示文摘	Seitz T Janosch P	1996	Mol Cell Biol1996，16，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示